40 results on '"Brundage M"'
Search Results
2. EP13.01-012 Exploring Factors Affecting Variability in Lung Cancer Outcomes Across Southeastern Ontario, Canada
3. EP04.01-024 Influence of Lung Diagnostic Assessment Program on Health Resource Utilization in Lung Cancer in Southeastern Ontario, Canada
4. PO-1031 Canadian Radiation Oncology 2020 Work Engagement and Burnout Survey
5. CCTG SC.24/TROG 17.06: A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases
6. OC-0075: The Canadian Association of Radiation Oncology 2019 workforce and technology utilization study
7. Geographic Accessibility to Radiotherapy in Canada and Greenland for Indigenous Populations: A Quantitative Approach to Highlighting Inequities and Exploring Solutions
8. PV-0252 From theory to practice: assessing the use of radiotherapy in population based cancer registries
9. OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer
10. A Prospective Study Validating the EORTC QLQ–BM22 Bone Metastases Module in Patients With Painful Bone Metastases
11. Minimal Clinically Important Differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL Modules in Patients With Bone Metastases
12. The Impact of Radiation Oncology Outreach Activities on the Utilization of Radiation Therapy
13. Measuring the Quality of Personal Care in Patients Undergoing Radiation Therapy for Prostate Cancer
14. Dexamethasone Versus Placebo in the Prophylaxis of Radiation-induced Pain Flare Following Palliative Radiation Therapy for Bone Metastases: A Double-blind Randomized, Controlled, Superiority Trial
15. Assessment of Current Peer Review Practices Across Canadian Radiation Oncology Centers
16. Radiation Therapy Quality of Care Indicators for Invasive Breast Cancer
17. Implementing a Program of Radiation Oncology Peer Review Across Multiple Cancer Centers in Ontario: A Quantitative and Qualitative Analysis
18. 2531 Measuring the quality of personal care in prostate cancer radiotherapy
19. Radiation Therapy Quality of Care Indicators for Locally Advanced Cervical Cancer: A Consensus Guideline
20. Measuring the Quality of Personal Care in Prostate Cancer Radiation Therapy: What Aspects of Care Are Important to Patients?
21. Response and Quality of Life (QOL) Outcomes in a Randomized Trial of Single Versus Multiple Fractions (Fx) for Re-irradiation (RE-RT) of Painful Bone Metastases (PBM): NCIC CTG SC.20
22. Final Analysis of Intergroup Randomized Phase III Study of Androgen Deprivation Therapy (ADT) ± Radiation Therapy (RT) in Locally Advanced Prostate Cancer (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)
23. Electron Therapy for Nonmelanoma Skin Cancers: Computer Simulated Bolus Versus Actual Physical Bolus for Treatment Planning
24. The Prostate Cancer Risk Stratification (ProCaRS) Project: Recursive Partitioning Risk Stratification Analysis
25. The Prostate Cancer Risk Stratification (ProCaRS) Project: Database Construction and Outcome Analysis
26. Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial
27. Radiation Oncology Workforce Recruitment, Training Characteristics, and Migration Trends: A Survey of Radiation Oncologists in Canada
28. 26 DEVELOPMENT OF CANADIAN QUALITY INDICATORS FOR RADIOTHERAPY OF LOCALIZED PROSTATE CANCER
29. 48 The importance of peer review in assuring quality of radiotherapy treatment planning: Results of a six-year experience
30. 218 Prognostic expectations for patients with glioblastoma multiforme in a population-based cohort
31. 37 PSA Doubling Time (PSA-DT) as a surrogate for prostate cancer-specific mortality in a population-based cohort of men treated with curative intent
32. 66 The Canadian radiation oncology workforce: Projecting concordance of supply and demand (2006–2016)
33. A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study
34. 107 Is There an Increased Role for Megavoltage CT Imaging in Radiation Therapy (and Beyond)?
35. 141 GBM, Are there long-term survivors with glioblastoma? Results of a population-based study
36. 86 Cobalt-based tomotherapy: State-of-the-art radiotherapy without a linac
37. Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer; NCIC CTG SC.15
38. US Army portable power programs
39. Characteristics of lung cancer patients entered on a Canadian palliative radiotherapy study (National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC.15 study)
40. Do doctors know when their patients don't?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.